Phase II Trial of Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Nov 2012
At a glance
- Drugs Dutasteride (Primary) ; Testosterone (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2012 Planned End Date changed from 1 Feb 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.